Some visit links earn us a commission.

Tirzepatide vs semaglutide cost: compounded from $69 vs $59 a month

Prices checked November 16, 2026

Paying cash on November 16, 2026, tirzepatide costs from $69 a month compounded (drug price) or $299 as Zepbound, and semaglutide from $59 a month compounded (drug price) or $149 as the Wegovy pill.

No insurance needed. Two programs to check.

Tirzepatide and semaglutide are two different medicines. Eli Lilly sells tirzepatide as Zepbound and Mounjaro, and Novo Nordisk sells semaglutide as Wegovy and Ozempic. Pharmacies also compound both, and that is where the lowest cash prices are. The FDA has not approved the compounded versions.

Tirzepatide vs Semaglutide, side by side

Tirzepatide and semaglutide compared on brand names, cash price, list price, savings cards, Medicare, dosing and weight loss
TirzepatideSemaglutide
Brand names
Zepbound for weight loss, Mounjaro for type 2 diabetesWegovy for weight loss, Ozempic for type 2 diabetes
Made by
Eli LillyNovo Nordisk
Compounded, cash
From $69 a month at Collective (drug price, plus a yearly membership), or $129 at Eden with no yearly membershipFrom $59 a month at Collective (drug price, plus a yearly membership), or $79 at CoreAge Rx with no yearly membership
Brand name for weight loss, cash
Zepbound at LillyDirect: $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and upWegovy at NovoCare: $349 a month for the pen and $399 for the 7.2 mg HD pen. The pill: $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg
Brand name for type 2 diabetes, cash
Mounjaro at LillyDirect: $499 a monthOzempic at NovoCare: $349 to $499 a month by dose
List price before insurance
Zepbound $499 to $1,086.37 a fill. Mounjaro $1,112.16 a fillWegovy $1,349.02 a fill. Ozempic $1,027.51 a fill
Savings card, with commercial insurance
Zepbound: as low as $25 for a 1, 2 or 3-month Rx (annual max $1,300), until December 31, 2026Wegovy: as low as $25/mo (max $100/mo off)
Medicare GLP-1 Bridge
$50 a month, Zepbound KwikPen only$50 a month
How often
Once a week, by injectionOnce a week by injection. The Wegovy pill is once a day
Weight loss in SURMOUNT-5, the head-to-head trial
20.2 percent of body weight on average at 72 weeks13.7 percent of body weight on average at 72 weeks

Cash prices are the sellers' own, checked November 16, 2026. You need a prescription for every row.

Compounded tirzepatide vs compounded semaglutide

Compounded tirzepatide costs from $69 a month at Collective (drug price, plus a yearly membership), or $129 at Eden with no yearly membership. Compounded semaglutide costs from $59 a month at Collective (drug price, plus a yearly membership), or $79 at CoreAge Rx with no yearly membership. At the lowest price on each, tirzepatide costs $10 more a month.

A licensed pharmacy makes a compounded drug against a prescription. The FDA has not approved it and does not review it before it is sold. Every program's price is on tirzepatide cost and semaglutide cost.

Brand-name cost without insurance

For weight loss, LillyDirect sells Zepbound at $299 at 2.5 mg, $399 at 5 mg and $449 to $699 at 7.5 mg and up. NovoCare sells Wegovy at $349 a month for the pen and $399 for the 7.2 mg HD pen, and the Wegovy pill at $149 at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg.

For type 2 diabetes, LillyDirect sells Mounjaro at $499 a month and NovoCare sells Ozempic at $349 to $499 a month by dose.

Those are the makers' cash prices. Their list prices, before insurance or any discount, are $499 to $1,086.37 a fill for Zepbound and $1,112.16 a fill for Mounjaro, against $1,349.02 a fill for Wegovy and $1,027.51 a fill for Ozempic. Each brand by dose: Zepbound cost, Wegovy cost, Mounjaro cost and Ozempic cost.

Which one took off more weight

One trial has put the two against each other for weight loss. SURMOUNT-5 gave 751 adults with obesity and no type 2 diabetes the highest dose of tirzepatide or semaglutide they could tolerate, once a week for 72 weeks. Tirzepatide took off 20.2 percent of body weight on average and semaglutide 13.7 percent. Eli Lilly paid for the trial, and everyone in it knew which drug they were on.

The doses were 10 mg or 15 mg of tirzepatide and 1.7 mg or 2.4 mg of semaglutide. We set out the design and its limits in semaglutide vs tirzepatide, the head-to-head results.

Dosing schedule

Both are weekly injections that start low and step up. The Zepbound label starts at 2.5 mg for 4 weeks and moves to 5 mg after 4 weeks, then 2.5 mg increments after at least 4 weeks on the current dose. It names 5 mg, 10 mg or 15 mg as the doses to stay on.

The Wegovy label starts at 0.25 mg, weeks 1 to 4, then 0.5 mg weeks 5 to 8, 1 mg weeks 9 to 12, 1.7 mg weeks 13 to 16. From week 17 the dose is 1.7 mg or 2.4 mg, and the label allows up to 7.2 mg weekly. The steps by week: Zepbound dosing and Wegovy dosing.

What savings cards and Medicare do for each

The makers' savings cards need commercial insurance that covers the drug. Zepbound's card terms read as low as $25 for a 1, 2 or 3-month Rx (annual max $1,300), until December 31, 2026. Wegovy's read as low as $25/mo (max $100/mo off). Neither works with Medicare or Medicaid.

Medicare's GLP-1 Bridge charges $50 a month to Part D members who qualify, from July 1, 2026 to December 31, 2027, and its list covers Wegovy and the Zepbound KwikPen. Ozempic and Mounjaro are not on that list.

People with type 2 diabetes or sleep apnea are outside the Bridge. Medicare says their Part D plan might cover the drug instead.

Questions people ask

Is tirzepatide more expensive than semaglutide?
Compounded, yes: tirzepatide starts at $69 a month and semaglutide at $59, both drug price. Among the brands, Zepbound starts at $299 a month at LillyDirect, the Wegovy pen at $349 and the Wegovy pill at $149 at NovoCare.
Which works better for weight loss, tirzepatide or semaglutide?
In SURMOUNT-5, the one head-to-head trial, tirzepatide took off 20.2 percent of body weight on average and semaglutide 13.7 percent over 72 weeks, in adults with obesity and no type 2 diabetes.
Are tirzepatide and semaglutide the same thing?
No. Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on the GLP-1 receptor and a second one, GIP. Eli Lilly makes tirzepatide and Novo Nordisk makes semaglutide.
Does Medicare cover tirzepatide or semaglutide?
The Medicare GLP-1 Bridge charges $50 a month for Wegovy and the Zepbound KwikPen to Part D members who qualify. People with type 2 diabetes are outside the Bridge, and Medicare says their Part D plan might cover the drug.

Compare other GLP-1 medications

Sources

Evidence checked November 15, 2026

Every figure above is taken from the document beside it, the FDA label or the trial that produced it, so you can read the source instead of trusting us. How we check sources.

8 documents

  1. Zepbound's approved uses, its dose steps and how tirzepatide worksFDA prescribing information for Zepbound (DailyMed, revised August 2026)
  2. Wegovy's approved uses, its dose steps and how semaglutide worksFDA prescribing information for Wegovy, injection and tablets (DailyMed, revised June 2026)
  3. SURMOUNT-5: tirzepatide against semaglutide in 751 adults with obesity and no type 2 diabetes, 20.2 percent against 13.7 percent of body weight at 72 weeksAronne LJ et al. N Engl J Med 2025;393(1):26-36 (PubMed 40353578)
  4. The FDA has not approved compounded drugs and does not review them before they are soldFDA's concerns with unapproved GLP-1 drugs used for weight loss (FDA)
  5. Which GLP-1 drugs the Medicare GLP-1 Bridge covers, who qualifies and who is outside itWeight loss drugs (Medicare.gov)
  6. The Bridge's $50 copay and its dates, July 1, 2026 to December 31, 2027Medicare GLP-1 Bridge (CMS)
  7. Mounjaro's list price for one fill, before insurance or discountsMounjaro cost information (Eli Lilly)
  8. Zepbound's list price range for one fill, before insurance or discountsZepbound cost information (Eli Lilly)

Prices from the programs' own pages, LillyDirect, NovoCare and the makers' list price and savings card pages, checked November 16. How we check prices.